BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8215640)

  • 61. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans.
    van Gelder T; Baan CC; Balk AH; Knoop CJ; Holweg CT; van der Meer P; Mochtar B; Zondervan PE; Niesters HG; Weimar W
    Transplantation; 1998 Feb; 65(3):405-10. PubMed ID: 9484761
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation.
    Yang SY; Denning SM; Mizuno S; Dupont B; Haynes BF
    J Exp Med; 1988 Oct; 168(4):1457-68. PubMed ID: 3049912
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.
    Chavin KD; Lau HT; Bromberg JS
    Transplantation; 1992 Aug; 54(2):286-91. PubMed ID: 1353913
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody.
    Pearson TC; Bushell AR; Darby CR; West LJ; Morris PJ; Wood KJ
    Clin Exp Immunol; 1993 May; 92(2):211-7. PubMed ID: 8097975
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
    Gray JD; Hirokawa M; Ohtsuka K; Horwitz DA
    J Immunol; 1998 Mar; 160(5):2248-54. PubMed ID: 9498764
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids.
    Ferran C; Dy M; Merite S; Sheehan K; Schreiber R; Leboulenger F; Landais P; Bluestone J; Bach JF; Chatenoud L
    Transplantation; 1990 Oct; 50(4):642-8. PubMed ID: 1699310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the Th1 cytokine mRNA in grafts.
    Takeuchi T; Ueki T; Sunaga S; Ikuta K; Sasaki Y; Li B; Moriyama N; Miyazaki J; Kawabe K
    Transplantation; 1997 Jul; 64(1):152-7. PubMed ID: 9233716
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system.
    Ayroldi E; Migliorati G; Cannarile L; Moraca R; Delfino DV; Riccardi C
    Blood; 1997 May; 89(10):3717-26. PubMed ID: 9160677
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2-independent pathway in CD3+ large granular lymphocytes.
    Loughran TP; Aprile JA; Ruscetti FW
    Blood; 1990 Feb; 75(4):935-40. PubMed ID: 2302461
    [TBL] [Abstract][Full Text] [Related]  

  • 76. T-cell malignancies with mature phenotypes: altered cell cycle regulation by HLA class I molecules.
    Turco MC; Alfinito F; De Felice M; Lamberti A; Ferrone S; Venuta S
    Blood; 1991 Oct; 78(8):2045-52. PubMed ID: 1680497
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma.
    Jarnicki AG; Fitzpatrick DR; Robinson BW; Bielefeldt-Ohmann H
    Cancer Lett; 1996 May; 103(1):1-9. PubMed ID: 8616801
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.
    Contreras JL; Wang PX; Eckhoff DE; Lobashevsky AL; Asiedu C; Frenette L; Robbin ML; Hubbard WJ; Cartner S; Nadler S; Cook WJ; Sharff J; Shiloach J; Thomas FT; Neville DM; Thomas JM
    Transplantation; 1998 May; 65(9):1159-69. PubMed ID: 9603161
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytotoxic cell proteinase gene expression and cytolytic activity by anti-CD3-activated cytotoxic T lymphocytes is sensitive to cyclosporin A but is not dependent on interleukin-2 synthesis.
    Kaiser M; Brooks-Kaiser J; Fitzpatrick L; Bleackley RC; Hoskin DW
    J Leukoc Biol; 1993 Nov; 54(5):458-64. PubMed ID: 8228625
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IL-3 dependence of a Thy-1lo, B220+, IL-3 receptor-positive antigen-specific DTH-initiating clone.
    Millet I; Ferreri NR; Ramabhadran R; Askenase PW
    Cell Immunol; 1992 Aug; 143(1):154-69. PubMed ID: 1352484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.